The literature regarding the use of medication for impulsive aggression, both in a prison setting and outside of prison, is briefly reviewed. The rationale for using oxcarbazepine for impulsive aggression in prison is presented, focusing on the evidence (though limited) of efficacy, the lack of frequent significant side effects, and the cost/benefit ratio, compared with other options.